title: Safety of denosumab in dialysis patients on calcium and vitamin D supplements.
authors.affiliation: Department of Nephrology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom.
authors.forename: Asad
authors.initials: A
authors.lastname: Ullah
authors.affiliation: Department of Nephrology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom.
authors.forename: K
authors.initials: K
authors.lastname: Abdulnabi
authors.affiliation: Department of Nephrology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom.
authors.forename: A
authors.initials: A
authors.lastname: Khalil
authors.affiliation: Department of Nephrology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom.
authors.forename: J
authors.initials: J
authors.lastname: Alexander
authors.affiliation: Department of Nephrology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom.
authors.forename: P
authors.initials: P
authors.lastname: Pai
authors.affiliation: Clinical Biochemistry and Metabolic Medicine, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom.
authors.forename: V
authors.initials: V
authors.lastname: Mishra
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000097:blood; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D002118:Calcium / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D000069448:Denosumab / Q000009:adverse effects*; D019587:Dietary Supplements / Q000009:adverse effects; D017809:Fatal Outcome; D006801:Humans; D006996:Hypocalcemia / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D012074:Remission Induction; D006435:Renal Dialysis / Q000009:adverse effects; D051436:Renal Insufficiency, Chronic / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014807:Vitamin D / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D015415:Biomarkers; D050071:Bone Density Conservation Agents; D014807:Vitamin D; D000069448:Denosumab; D002118:Calcium